Regina Steringer-Mascherbauer Selected Research

Nitric Oxide (Nitrogen Monoxide)

11/2014

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Regina Steringer-Mascherbauer Research Topics

Disease

11	Pulmonary Hypertension 07/2023 - 11/2014
5	Pulmonary Arterial Hypertension 02/2021 - 10/2017
3	Heart Failure 01/2022 - 11/2014
2	Hemorrhage 02/2021 - 01/2021
2	Hemoptysis 02/2021 - 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Iron Deficiencies 01/2018
1	Disease Progression 01/2018
1	Inflammation (Inflammations) 01/2018
1	Anemia 01/2018
1	Diastolic Heart Failure 11/2014

Drug/Important Bio-Agent (IBA)

6	treprostinil FDA Link 07/2023 - 10/2017
5	riociguatIBA 01/2022 - 11/2014
3	Soluble Guanylyl CyclaseIBA 02/2021 - 11/2014
2	Vasodilator Agents (Vasodilators)IBA 01/2022 - 12/2016
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021 - 01/2019
2	ProstaglandinsIBA 10/2020 - 10/2017
1	HepcidinsIBA 01/2018
1	IronIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2014
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 11/2014

Therapy/Procedure

4	Therapeutics 07/2023 - 12/2016
2	Implantable Infusion Pumps 07/2023 - 10/2020
2	Endarterectomy (Thromboendarterectomy) 07/2023 - 01/2019